In the evolving landscape of modern medicine, few figures have challenged established orthodoxies as consistently as Dr. Howard Schubiner. A clinical professor at the Michigan State University College of Human Medicine and an internist with over 100 scientific publications, Schubiner has spent the last two decades at the forefront of a paradigm shift. His work suggests that a vast array of chronic conditions—from debilitating back pain to treatment-resistant depression—are not necessarily the result of structural damage or chemical imbalances, but are instead the product of "neuroplastic" circuits in the brain.
In a recent comprehensive dialogue on the Mad in America podcast with author Brooke Siem, Dr. Schubiner detailed the science behind his most recent book, Unlearn Your Pain. The discussion illuminated a radical yet evidence-based approach to healing that centers on "predictive processing," the power of belief, and the brain’s subconscious attempts to protect the individual from perceived danger.
Main Facts: The Predictive Brain and the Nature of Symptoms
At the core of Dr. Schubiner’s thesis is a concept known in high-level neuroscience as "predictive processing." Contrary to the traditional view that our senses act as passive windows to the world, modern neuroscience suggests that the brain actively creates our reality. We do not "see" with our eyes; the auditory cortex "creates" what we hear. Similarly, pain is an output of the brain, not a simple input from the body.
Dr. Schubiner argues that chronic symptoms—including pain, fatigue, anxiety, and depression—are often "real symptoms generated automatically" by the subconscious brain. These symptoms act as danger signals. When the brain perceives a threat—whether physical, emotional, or spiritual—it may activate a neural circuit that produces a physical sensation to alert or protect the individual.
The implications of this are profound: if a symptom is generated by a neural circuit rather than permanent structural damage, that symptom is "neuroplastic." Because the brain is capable of change, these circuits can be "unlearned," offering a pathway to recovery for patients who have been told their conditions are incurable or purely structural.
Chronology: From Medical Orthodoxy to Neuroplastic Innovation
Dr. Schubiner’s journey into mind-body medicine began mid-career, following 18 years as a traditional medical school faculty member and researcher. His trajectory changed after encountering the work of Dr. John Sarno, the late NYU professor and author of Mind Over Back Pain. Sarno’s controversial yet highly successful approach focused on Tension Myositis Syndrome (TMS), suggesting that most back pain was a result of repressed emotions rather than spinal abnormalities.
Inspired by Sarno’s clinical success, Schubiner transitioned from traditional internal medicine to a deep immersion in the science of neuroplasticity. Over the last 23 years, he has moved beyond Sarno’s initial theories, integrating modern neuroscience and conducting high-level randomized controlled trials (RCTs). These studies have aimed to provide a rigorous scientific foundation for what was once considered "alternative" medicine.
His work has culminated in the development and testing of specific therapeutic modalities: Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET). These treatments have now been validated in clinical settings, often outperforming the "gold standard" of Cognitive Behavioral Therapy (CBT) for chronic pain and associated psychological distress.
Supporting Data: Placebos, Nocebos, and the Power of Expectation
To understand why neuroplastic treatments work, one must look at the data regarding the placebo and nocebo effects. Dr. Schubiner points to antidepressant trials as a primary example. In many randomized controlled trials, the efficacy of the placebo is nearly as high as the active medication. This does not mean the patient’s improvement is "fake"; rather, it indicates that the belief in the treatment has the power to change the brain’s neural circuits, effectively reducing the symptoms of depression through neuroplasticity.
The "nocebo" effect—the production of negative symptoms due to negative expectations—is equally powerful. Schubiner cites a striking example from a clinical trial involving a suicidal patient who attempted to overdose by swallowing a bottle of study pills. The patient collapsed with dangerously low blood pressure and a thready pulse. However, once the researchers revealed he was in the "placebo arm" of the study and had only swallowed sugar pills, his vital signs stabilized almost instantly. His brain had created a life-threatening physiological response based entirely on the prediction of toxicity.
Further supporting data comes from a study conducted by Dr. Brandon Yarns at UCLA. The study focused on veterans who had suffered from musculoskeletal pain for over 20 years. Surprisingly, the participants who saw the greatest benefit from Emotional Awareness and Expression Therapy were those with co-existing "triple-threat" diagnoses: chronic pain, anxiety/depression, and PTSD. This contradicts the conventional medical wisdom that patients with multiple comorbidities are the hardest to treat. Instead, it suggests that when the underlying emotional "danger signals" are addressed, the entire cluster of symptoms can collapse.
Case Study: The Physician and the Power of Authenticity
A pivotal example shared by Dr. Schubiner involves a female physician suffering from debilitating pelvic and back pain. Despite undergoing various medical evaluations that showed only mild "degenerative changes" (which are common in asymptomatic populations), her pain persisted.
The breakthrough occurred when she began exploring the mind-body connection. She realized her pain began on the day of her medical school graduation—a day that followed the sudden death of both parents. Further exploration revealed a lifelong pattern of "people-pleasing" and the suppression of her own needs to avoid conflict.
The "cure" was not found in surgery or medication, but in a moment of radical authenticity. After a lunch where she finally stood up for herself and said "no" to a friend’s request, her pain vanished instantly. This "N of 1" experience provided the evidence her brain needed: the pain was a protective signal related to the stress of self-suppression, not a structural failure of her spine or pelvis. By changing how she related to herself and others, her chronic symptoms eventually resolved completely.
Official Responses and Critiques of the Psychiatric Model
Dr. Schubiner’s work serves as a direct critique of the prevailing "biomedical model" in psychiatry and pain management. He challenges the widely held belief that depression is primarily a "chemical imbalance" of serotonin—a theory that recent comprehensive reviews have largely debunked.
According to Schubiner, the psychiatric community often inadvertently induces a "nocebo effect" by telling patients they have "treatment-resistant" depression or "relapsing" conditions that require lifelong medication. This narrative reinforces the brain’s "danger mode," making recovery more difficult by convincing the patient they are structurally damaged or genetically flawed.
In the context of antidepressant withdrawal—a topic championed by Brooke Siem—Schubiner suggests that while physiological withdrawal is a real and difficult process, the brain’s fear of withdrawal can also generate symptoms. He proposes "N of 1" trials for patients tapering off medication, where they are "blinded" to their daily dose by a partner. This helps distinguish between the physiological effects of the drug and the brain’s predictive anxiety, empowering the patient to move forward with less fear.
Implications: A New Path for Chronic Care
The implications of Dr. Schubiner’s research suggest a necessary overhaul of how the medical system treats chronic "invisible" illnesses.
1. From Structural to Functional Diagnosis
Instead of focusing solely on MRIs and blood tests—which often show "normal" age-related wear and tear—doctors must look for the "evidence of neuroplasticity." This includes symptoms that vary by time of day, shift in location, or are triggered by specific social situations or emotional states. If a symptom can turn "off" for even ten seconds, it is a neural circuit, not a broken bone.
2. The Role of Agency and Connection
The primary treatments developed by Schubiner and his colleagues—PRT and EAET—focus on restoring a patient’s agency. By teaching patients to view their symptoms as "safe" (though painful) signals from a confused brain, they can reduce the fear that fuels the neural loop. Furthermore, EAET emphasizes "Emotional Awareness," helping patients process suppressed anger, sadness, and guilt in a safe, imaginative environment to "rewire" the trauma responses stored in the brain.
3. Redefining Hope in Chronic Fatigue and Pain
For the millions suffering from Fibromyalgia, Chronic Fatigue Syndrome (ME/CFS), and Irritable Bowel Syndrome (IBS), the neuroplastic model offers a message of hope. By shifting the focus from "managing an incurable disease" to "retraining the brain’s danger response," recovery becomes a biological possibility.
Conclusion
Dr. Howard Schubiner’s work bridges the gap between high-level neuroscience and clinical compassion. By demonstrating that the brain can create real, debilitating physical symptoms in response to emotional and environmental stressors, he provides a scientific framework for the "mind-body" connection.
As the medical community continues to grapple with the limits of the biomedical model, the shift toward understanding neuroplasticity and predictive processing offers a promising alternative. For patients trapped in cycles of chronic pain and mental distress, the message is clear: the brain that learned the pain has the inherent capacity to unlearn it, provided it is given the right tools of safety, authenticity, and self-compassion.
